drugset / Trial / NCT02597257

Efficacy and Safety of Lidocaine Infusion Treatment in Management of Neuropathic Pain

NCT02597257

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The investigators conducted a randomized, Double blind, and Controlled Study to evaluate the Efficacy and safety of Lidocaine Infusion Treatment in Management of Neuropathic pain.

Timeline

Start
2015-08
Primary completion
2016-07
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 3 mg/kg Intravenous